Free Trial!
Today’s Best Stocks To Trade! Click Here
To receive our complimentary newsletters please copy and paste http://www.emergingmarketsllc.com in to your web browser. On the upper right hand corner of the homepage enter your email address and click sign up. You will receive a confirmation email, click the link and your free subscription will be active.
Accentia Biopharmaceuticals, Inc. closed at $1.35 up $.26 (23.85%) with volume of 5,331,535 Biovest International, Inc. (OTCBB:BVTI - News), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI - News), yesterday reported what the Company believes to be highly encouraging blinded results from its randomized controlled pivotal Phase 3 Fast-Tracked clinical trial of BiovaxID (anti-idiotype vaccine) for the treatment of indolent follicular non-Hodgkin's lymphoma (NHL), an often fatal blood cancer. The Company reported blinded disease-free survival data for those patients that have completed 36 months of follow-up subsequent to randomization in both the treatment and control arms, with one arm demonstrating 100% improvement in disease-free survival over the other arm. Disease-free survival (how long patients remain in cancer-free remission) is the primary endpoint of the study.
About Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, develops and commercializes drug candidates that are in late-stage clinical development based on active pharmaceutical ingredients in the therapeutic areas of respiratory disease and oncology. It operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products. Its products, which are under Phase III clinical trials, include SinuNase for the treatment of chronic rhinosinusitis; BiovaxID, a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkins lymphoma; and Revimmune for the treatment of multiple sclerosis, an autoimmune disease that affects the central nervous system, and various autoimmune diseases, including systemic lupus, myasthenia gravis, and aplastic anemia. This segment also provides various consulting services relating to biopharmaceutical product development; and engages in the production of custom biologic products and cell culture instruments and systems for biopharmaceutical and biotechnology companies, medical schools, universities, hospitals, and research institutions. The Specialty Pharmaceuticals segment markets and sells pharmaceutical products that are developed primarily by third-party development partners. Its products comprise Respi-TANN, a prescription antitussive decongestant for temporary relief of cough and nasal congestion; SinuTest, a test used in connection with the diagnosis of chronic sinusitis; and Zinotic, a treatment of superficial infections of the external ear. This segment's products under development include AllerNase, a formulated suspension of an intranasal topical steroid indicated for the treatment of allergic and non-allergic rhinitis; and Emezine, a product for control of nausea and vomiting. The company was founded in 2002 and is headquartered in Tampa, Florida.
Source Interlink Companies, Inc. closed at $1.81 up $.58 (47.15%) with volume of 3,909,221 NCircle Entertainment yesterday announced a theatrical distribution agreement with Kidtoons, a division of The Bigger Picture, an AccessIT company (Nasdaq: AIXD - News), to feature award-winning animated children's series Pocoyo in select movie theaters across the United States beginning in September 2008. Kidtoons is devoted to bringing parents and kids together by showcasing G-rated animated movies in theaters throughout the country every weekend. In addition to presenting matinee movies on Saturdays and Sundays, Kidtoons theaters also feature cartoon shorts, music videos and sing-a-longs prior to the feature presentation. Participating theater chains include Abingdon Cinemall, Allen, Atlas, Emagine, Marquee, Neighborhood, AccessIT's Pavilion Theatre, National Amusements, Rave Motion Pictures, Republic Theatre Group, Showplace and UltraStar.
About Source Interlink Companies, Inc.
Source Interlink Companies, Inc. operates as a marketing, merchandising, and fulfillment company of entertainment products in North America. Its entertainment products include DVDs, music CDs, magazines, books, and related items. The company engages in the publication of print and digital content to the enthusiast community in the United States via publications, Web sites, and events; distribution and fulfillment of entertainment products to retail chains and direct-to-consumers through the Internet; import and export of periodicals sold in approximately 100 markets worldwide; and coordination of product selection and placement for impulse items sold at checkout counters. It also involves in the processing and collection of rebate claims; and design, manufacture, and installation of metal wire display fixtures in retail chains. The company serves bookstore chains, music stores, other specialty retailers, grocery stores, drug stores, and mass merchandise retailers. As of January 31, 2008, its media content portfolio comprises 76 publications, 90 related Web sites, approximately 65 events, 2 television programs, and approximately 400 branded products. The company was founded in 1988 and is headquartered in Bonita Springs, Florida.
Nortel Networks Corporation closed at $9.20 up $1.09 (13.44%) with volume of 22,417,755 Deutsche Bahn AG announced today that there adding powerful communications and train management capabilities along its busy 24,000 kilometer (almost 15,000 mile) rail network by increasing communications capacity and improving cost-effectiveness with a GSM-R upgrade from Nortel(1) (Toronto:NT.TO - News)(NYSE:NT - News). Nortel first deployed GSM-R - a wireless technology, specially designed to meet the needs of railways - for Deutsche Bahn in 1999. The current upgrade is key to Deutsche Bahn's strategic plans for reducing operational costs and maintaining high standards of passenger safety on trains travelling at higher speeds on routes across Germany.
About Nortel Networks Corporation Nortel Networks Corporation designs, develops, engineers, markets, sells, supplies, licenses, installs, services, and supports networking solutions worldwide. Its Carrier Networks segment offers wireline and wireless networks to supply mobile voice, data, and multimedia communications services to individuals and enterprises using cellular telephones, personal digital assistants, laptops, soft-clients, and other wireless computing and communications devices. This segment also provides circuit- and packet-based voice switching products that provide local, toll, long distance, and gateway capabilities for local and long distance telephone companies, wireless service providers, cable operators, and other service providers. The company's Enterprise Solutions segment offers enterprise communications solutions for businesses in various industries, including healthcare and financial service providers, retailers, manufacturers, utilities, educational institutions, and government agencies. Nortel's Metro Ethernet Networks segment provides carrier ethernet switching, optical networking, and multi-service switching products. Its Global Services segment offers network implementation services, including network integration, planning, installation, optimization, and security services; network support services, such as technical support, hardware maintenance, equipment spares logistics, and on-site engineers; network managed services, including services related to the monitoring and management of customer networks, and providing network managed service options; and network application services, such as applications development, integration, and communications-enabled application solutions. Nortel has strategic alliances with Microsoft Corporation; Dell, Inc.; and IBM, as well as joint-venture with LG Electronics, Inc. and collaboration with IPC Systems, Inc. The company was founded in 1914 and is headquartered in Toronto, Canada.
TGC Industries, Inc. closed at $8.21 up $.98 (13.55%) with volume of 486,237 TGC Industries, Inc. (Nasdaq: TGE - News) today announced that its President and Chief Executive Officer, Wayne Whitener, will be a speaker at the Energy Capital Investment Symposium at the Westin Galleria in Houston, Texas on June 11, 2008. Mr. Whitener is scheduled to speak at 10:00 a.m. Central Time. His presentation will be broadcast live over the Internet and is expected to last approximately twenty minutes. The webcast link will be available on the Company's website at http://www.tgcseismic.com. A replay of his presentation will be archived on the website shortly after the presentation has been concluded.
About TGC Industries, Inc.
TGC Industries, Inc. provides seismic data acquisition services primarily to onshore oil and natural gas exploration and development companies in the continental United States. The company conducts 3-D surveys to acquire geophysical data; and owns a data bank that contains gravity data and magnetic data, from oil and natural gas producing areas located in the United States. As of December 31, 2007, it operated eight land-based seismic data acquisition crews, which supplied seismic data to companies engaged in the domestic exploration and development of oil and natural gas on land and in land-to-water transition areas. The company was founded in 1967 and is headquartered in Plano, Texas.
About Emerging Markets Consulting, LLC Emerging Markets Consulting, LLC is an investor relations and consulting firm serving carefully selected micro cap and small cap clients. Services available include turnkey investor relations services, consulting, marketing and related services needed by publicly traded companies. EMC is unique in that they only work with companies after a stringent due diligence process and they also work with a limited number of clients in order to provide service that is exceptional. The above referenced companies are not clients of Emerging Markets and no compensation has been paid for the exposure provided by this report.
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned. Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.
Please remember to go to www.emergingmarketsllc.com and enter your email address to sign up for our free newsletter.
CONTACT: Emerging Markets Consulting, LLC Tel: +1 321 206 6682 e-mail jamespainter@emergingmarketsllc.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
